Cubist Pharmaceuticals (CBST) Acquired By Merck (MRK)

The board of Merck & Co., Inc. (MRK) agreed on Monday to buy Lexington, Massachusetts-based Cubist Pharmaceuticals Inc. (CBST), a maker of antibiotics, for about $8.4 billion in cash, the company announced in a statement. Merck, the second-biggest U.S. drugmaker, would pay $102 per share in cash, representing a 35-percent premium over Cubist’s closing share […] View the full post at: Cubist Pharmaceuticals (CBST) Acquired By Merck (MRK) Related posts: Phillips-Van Heusen Acquires Hilfiger for $3 Billion S&P Raises Ford’s Credit Ratings